A Phase 2 Randomised, Double-Blind, Placebo-Controlled Exploratory Efficacy Study Of Sitaxsentan Sodium To Improve Impaired Exercise Tolerance In Subjects With Diastolic Heart Failure.
Phase of Trial: Phase II
Latest Information Update: 21 Mar 2012
At a glance
- Drugs Sitaxentan (Primary)
- Indications Heart failure
- Focus Therapeutic Use
- 12 Jul 2011 Additional trial location (Canada) added as reported by ClinicalTrials.gov.
- 08 Apr 2009 Company Encysive Pharmaceuticals change to Pfizer as trial sponsor/affiliate, Addition of trial centre as reported by ClinicalTrials.gov.
- 08 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.